After-hours movers: Broadcom, Levi, Human and more
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/21/2026
- Wall St gains on chip stocks recovery; earnings draw focus
- Oil prices rise to five-week high on US-Iran attacks, Houthi blockade threat
- Chip stocks extend global rebound following last week's rout
- Citi's Chew says U.S. stock positioning unwind may not be over
- Adobe, Salesforce and Intuit fall as Morgan Stanley begins cautious coverage
- U.S. to impose 50% tariff on most Canadian goods, including USMCA
- Intersnack to acquire Utz Brands at $14.25 per share in go-private deal
- NVIDIA reports 9.3% passive stake in Nebius
- Wall Street indexes fall, with Iran and earnings season in focus
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
BofA Securities Reiterates Buy Rating on CVS Health (CVS)
April 8, 2025 8:35 AM EDTBofA Securities analyst Michael Cherny reiterated a Buy rating and $80.00 price target on CVS Health (NYSE: CVS).
The analyst comments "CVS expects to meet or exceed its guidance for full year 2025 which we view positively heading into 1Q25 earnings on May 1st. In our view, setting... More
